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Abstract ArsA protein is the soluble subunit of the Ars anion
pump in the Escherichia coli membrane which extrudes arsenite
or antimonite from the cytoplasm. The molecular weight of the
subunit is 63 kDa. In the cell it hydrolyzes ATP, and the energy
released is used by the membrane-bound subunit ArsB to
transport the substrates across the membrane. We have obtained
two-dimensional crystals of ArsA in the presence of arsenite on
negatively-charged lipid monolayer composed of DMPS and
DOPC. These crystals have been studied using electron
microscopy of negatively-stained specimens followed by image
processing. The projection map obtained at 2.4 nm resolution
reveals a ring-like structure with threefold symmetry. Many
molecular assemblies with the same ring-shape and dimensions
were also seen dispersed on electron microscopy grids, prepared
directly from purified ArsA protein solution. Size-exclusion
chromatography of the protein sample with arsenite present
revealed that the majority of the protein particles in solution have
a molecular weight of about 180 kDa. Based on these
experiments, we conclude that in solution the ArsA ATPase
with substrate bound is mainly in a trimeric form.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
Arsenite (+3 oxidation state of arsenic) is extremely toxic to
most biological organisms, including prokaryotes, since it can
react directly with the sulfhydryl groups of proteins and thus
destroys their biological functions [1,2]. Many organisms
have, therefore, developed systems that can detoxify arseni-
cals. In prokaryotic cells, plasmids encoding arsenite-resis-
tance systems have been discovered [3,4]. The most important
component of the transport system is found to be an ATP-
coupled oxyanion pump in the cell membranes which cata-
lyzes extrusion of arsenite and antimonite so that the intercel-
lular concentration of the toxic substances is minimized [5].
The pump is a complex composed of two proteins, ArsA and
ArsB, which are separately encoded by the arsA and arsB
genes. ArsB is a 45 kDa integral membrane protein that is
postulated to be the oxyanion translocation part of the pump.
The 63 kDa soluble ArsA protein, on the other hand, is the
catalytic subunit, with As(III)/Sb(III)-stimulated ATPase ac-
tivity. It anchors with ArsB to form the arsenite anion pump
in the membrane [6,7]. When over-expressed in Escherichia
coli at high levels, the ArsA protein is mainly found in the
cytosol, from which it can be puri¢ed and characterized [8,9].
During the past decade, much work has been done in study-
ing the functions and biochemical properties of the ArsA pro-
tein. The protein consists of 583 amino acids. The N- and C-
terminal halves of the polypeptide (referred to as A1 and A2,
respectively) are homologous in sequence [10], with each half
having a consensus sequence as the binding site of phosphoryl
group of ATP. As an ATPase, ArsA is allosterically regulated
by the trivalent arsenic or antimonic. In the presence of ar-
senite or antimonite, the ATPase activity of ArsA is increased
greatly. It has been hypothesized that when the regulator
As(III) or Sb(III) binds to the allosteric site, the ArsA ATPase
undergoes a conformational change so that A1 and A2 do-
mains within the same monomer make contact with each oth-
er to form a catalytic site of ATP hydrolysis at the interface
between the two ATP binding sites [7]. There is evidence that
the covalent coordination of As(III) or Sb(III) atoms with SH
groups of cysteine residues Cys-113, Cys-172, and Cys-422 in
the ArsA polypeptide leads to conformational changes in the
protein which increases its ATPase activity [11,12]. It has been
proposed that the conformational change also leads to
changes in the oligomeric state of protein. Based on biochem-
istry and point mutation experiments, Rosen’s group has pro-
posed models describing changes in oligomeric state of ArsA
in di¡erent conditions [7,11]. It is suggested that in the pres-
ence of arsenite or antimonite, ArsA aggregates into dimers
while it is in the monomeric form in solution in the absence of
the trivalent anions [13]. This is referred to as the dimer model
in the current report.
Though extensive investigations on the functions and bio-
chemical properties of the ArsA protein have been made, a
full understanding of the arsenite-resistance mechanism in or-
ganisms is still lacking, largely due to the absence of direct
structural information. Recently, Zhou et al. [14] have ob-
tained three-dimensional crystals of ArsA, but the solution
of the protein structure has not yet been reported. In the
current work, we have examined the structure of ArsA on
lipid layer and in solution by electron microscopy (EM) and
size-exclusion chromatography. Using the lipid monolayer
technique, we obtained the two-dimensional (2D) crystals of
ArsA in the presence of arsenite on negatively charged lipids.
From the electron micrographs of the negatively-stained 2D
crystals, a projection map at 2.4 nm resolution was calculated.
A trimeric ring-like structure of ArsA ATPase was seen. In
addition, on EM grids directly prepared from solution of pu-
ri¢ed ArsA protein, the same ring-like structures as in the 2D
crystals were observed by EM. Furthermore, the majority of
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the protein particles were found to have a molecular weight of
about 180 kDa in the solution containing arsenite, corre-
sponding to ArsA trimers. Thus, we concluded that the
ArsA ATPase is in trimeric form in solution in the presence
of its allosteric substrate, contradictory to the dimer model
[7,11,15].
2. Materials and methods
2.1. Puri¢cation of ArsA ATPase
The wild type ArsA protein was expressed and puri¢ed as described
previously [16]. In short, E. coli strain SG20043 bearing plasmid R773
encoding the wild type ArsA protein (a kind gift from Dr. B.P. Rosen
of Wayne State University) was inoculated and cultured in LB me-
dium at 37‡C. The over-production of the protein was induced by the
addition of isopropyl-L-D-thiogalactoside (IPTG). The ArsA protein
was puri¢ed sequentially through ion-change Q-Sepharose, a⁄nity red
agarose, and size-exclusion Sepharyl S-200 columns to more than 95%
homogeneity and stored at 370‡C until use. The purity of ArsA
protein was checked by silver staining of samples separated by sodium
dodecylsulfate^polyacrylamide gel electrophoresis (SDS^PAGE). The
protein concentration was determined by a modi¢cation of the Lowry
method [17]. The ATPase activity of the protein was measured from
the release of inorganic phosphate according to Rosen et al. [8].
2.2. Size-exclusion HPLC of ArsA ATPase
The molecular weight of the ArsA ATPase oligomers in solution
was measured by size-exclusion HPLC. 50 Wl of protein sample of
1 mg/ml concentration was loaded onto a Shodex GS-403 analytical
size-exclusion column equilibrated with 20 mM MOPS^KOH, pH 7.5,
1 mM DTT, 2.5 mM MgCl2, 5 mM NaAsO2, 200 mM Na2SO4, and
developed at 0.5 ml/min. The system was powered with a Waters 600S
solvent delivery system controlled by Millennium control and data-
collection software and data collection was via a photodiode array
detector (Waters, Milford, MA, USA). Chromatograms were ex-
tracted from the photodiode array data at a wavelength of 280 nm.
The molecular weight of the ArsA oligomer was estimated by com-
parison with the retention times of a set of protein standards of
known molecular weight: ovalbumin (43 kDa), albumin (67 kDa),
alcohol dehydrogenase (150 kDa) and amylase (200 kDa). Each of
these protein standards was run on HPLC individually.
2.3. 2D crystallization of ArsA ATPase on lipid monolayer
For 2D crystallization of ArsA protein, the monolayer technique
developed by Uzgiris and Kornberg [18] was used. 15 Wl of puri¢ed
ArsA solution at a concentration of 10^20 Wg/ml was added into a
small Te£on well (4 mm in diameter and 0.5 mm in depth), in bu¡er
containing 20 mM MOPS^KOH (pH 5.5^7.5), 2.5 mM CaCl2 or
MgCl2, 5 mM NaAsO2 and 1 mM DTT. Then a droplet of 0.5^1.0
Wl lipid mixture composed of DMPS and DOPC in 1:5 molar ratio at
a concentration of 1.0 mg/ml, dissolved in chloroform/methanol (3:1,
v/v), was spread over the protein solution in the well. The Te£on well
was then incubated in a humid atmosphere at room temperature for
24^48 h. The amount of lipid sample added to the well was much
more than required to form a lipid monolayer. Thus, with the aper-
ture e¡ect, the lipid monolayer on the surface of protein solution
reached its highest pressure. The protein molecules may be adsorbed
to the negatively charged lipid layers by electrostatic force. As the
surface density of the protein molecules rises up they may arrange
themselves laterally into 2D crystals due to favorable interactions
between the protein molecules and the £uidity of the lipid layers.
2.4. EM and image processing
After incubation in the small Te£on well for proper period, the lipid
monolayers with 2D crystals on them were picked up on hydrophobic
carbon-coated EM grids. Brie£y, the grids were placed horizontally by
forceps onto the ¢lm at the air/water interface and picked up after
they reached the monolayer. Blotted o¡ the residual solution on the
grids, they were negatively stained with 1^2% uranyl acetate for 2^3
min. For those single molecules of ArsA ATPase, a drop of puri¢ed
protein solution with a concentration of about 10 Wg/ml was adsorbed
on carbon-coated EM grids for about 1 min then negatively stained
with uranyl acetate.
EM samples were examined and data collection was done in a
JEOL CX-200 transmission electron microscope. 2D crystals of
ArsA were photographed at a magni¢cation from 40 000^60 000
onto Kodak SQ-163 ¢lm. Judged by optical di¡raction, only ¢lms
with the best crystallinity and suitable defocus were selected and digi-
tized with the AGFA DUOSCAN camera system in a step size of
about 13 Wm/pixel. The calculated Fourier transform of the image was
indexed using SPECTRA program [19]. Subsequent processing steps
were all done using the MRC Image Processing Package [20], includ-
ing lattice re¢nement, lattice unbending, and amplitude and phase
extraction. The phase residuals of crystals were calculated for di¡erent
layer groups by the ALLSPACE program [21]. The ¢nal projection
map was calculated using the CCP4 Package [22].
2.5. Materials and reagents
MOPS was purchased from Merck. DTT were purchased from
Promega. Phospholipids DMPS and DOPC were purchased from
Table 1
Phase residuals (‡) of image 6295 calculated for 17 layer groups by ALLSPACE
Layer group Phase residue (no.) vs.
other spots (90‡ random)
Phase residue (no.) vs.
theoretical (45‡ random)
Target residual based on statistics taking
the Friedel weight into account
1 p1 17.1 32 12.3 32 ^
2 p2 25.7a 16 12.9 32 24.6
3b p12_b 61.8 9 40.1 6 19.6
3a p12_a 64.3 8 49.5 4 19.0
4b p121_b 39.6 9 4.1 6 19.6
4a p121_a 51.2 8 1.0 4 19.0
5b c12_b 61.8 9 40.1 6 19.6
5a c12_a 64.3 8 49.5 4 19.0
6 p222 70.5 33 12.9 32 20.7
7b p2221_b 48.3 33 13.0 32 20.7
7a p2221_a 39.6 33 12.9 32 20.7
8 p22121 55.1 33 15.1 32 20.7
9 c222 70.5 33 12.9 32 20.7
10 p4 56.9 36 13.1 32 20.4
11 p422 59.0 80 12.9 32 18.6
12 p4212 49.1 80 16.0 32 18.6
13 p3 7.4b 30 ^ ^ 17.1
14 p312 18.2b 69 1.4 6 17.4
15 p321 61.3 73 53.8 14 17.8
16 p6 58.9 76 44.4 32 18.7
17 p622 61.8 158 44.4 32 17.9
aTo be considered.
bAcceptable.
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Sigma. Q-Sepharose, reactive red 120-agarose (type 3000-CL) columns
were purchased from Sigma. Sephacryl S-200 (¢ne) columns were
purchased from Pharmacia. All the other reagents were purchased
locally in Beijing.
3. Results
3.1. 2D crystallization of ArsA ATPase on DMPS/DOPC
monolayer
Samples were picked up to grids and examined by EM at
di¡erent time intervals in order to check crystal formation. 2D
crystals of puri¢ed ArsA were obtained on negatively charged
DMPS/DOPC (1:5 in molar ratio), using the lipid monolayer
2D crystallization technique [18], when incubated for about 48
h at room temperature. The crystallization bu¡er contained 20
Wg/ml ArsA in 20 mM MOPS^KOH bu¡er (pH 7.5) with the
addition of 2.5 mM MgCl2, 5 mM NaAsO2 and 1 mM DTT.
During the 2D crystallization of ArsA on negatively
charged DMPS/DOPC monolayer, keeping the protein in its
stable and homogeneous conformation is one of the key fac-
tors. We found that the presence of DTT in solution is essen-
tial to keep the proteins stable. In its absence, no well-de¢ned
structures but only large amount of aggregates, probably
composed of denatured proteins, were observed on the mono-
layer (data not shown). As the speci¢c allosteric ligand of
ArsA, arsenite or antimonite leads the ATPase to a confor-
mation with higher activity [11,12]. Thus arsenite was added
to the protein solution in order to keep proteins in fairly
homogeneous conformation.
The ionic strength and pH of the solution are also impor-
tant factors for 2D crystallization of the ArsA proteins on
monolayer mediated by electrostatic adsorption. Bu¡ers con-
taining di¡erent concentrations of ions and with di¡erent pH
values were tried in our work. +2 cations were found to be
essential for the formation of 2D crystals of ArsA on nega-
tively-charged DMPS/DOPC monolayer. In the presence of
2.5 mM calcium, 2D crystals of ArsA in a small area were
obtained on DMPS/DOPC monolayer incubated at room
temperature over 48 h. When the calcium was replaced with
magnesium, well-ordered 2D crystals measuring up to several
micrometers were obtained at the room temperature over 24 h
(Fig. 1a). Variations of the pH from 5.5^7.5 were found to
have little e¡ect on the formation of 2D ArsA crystals.
3.2. Trimeric ring-like structure of ArsA obtained from 2D
crystals by EM and image processing
Structural data from 2D ArsA crystals were collected by
EM followed by image processing. Several hundred pictures
were recorded from di¡erent crystals and six of them were
processed. The Fourier transform showed a hexagonal pattern
(Fig. 1b). After lattice unbending of the images using the
MRC programs, the lattice parameters of the unit cell were
C
Fig. 1. EM and image processing of 2D ArsA crystals. A: Electron
micrograph of a negatively-stained 2D of ArsA grown on nega-
tively-charged DMPS/DOPC (1:5 in molar ratio) monolayer. The
crystallization bu¡er contained 20 Wg/ml ArsA in 20 mM MOPS^
KOH bu¡er (pH 7.5) with the addition of 2.5 mM MgCl2, 5 mM
NaAsO2, 1 mM DTT when incubated for about 48 h at room tem-
perature. The crystals are found to possess p3 layer group symme-
try. B: The computed di¡raction pattern from the original image.
The (31,3) re£ection at a resolution of 3.1 nm is indicated by an
arrowhead. C: Projection map from ArsA 2D crystals by EM and
image processing, averaged from six images with threefold symmetry
imposed. One unit cell is indicated. The trimeric ring-like structure
of 8.5 nm in diameter is seen. The possible way of assembly of
three monomers in one ring is indicated by the boat-shaped boxes.
Scale bar in (A) represents 100 nm.
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determined to be a = b = 9.6 nm and Q = 120‡. We used the
ALLSPACE program [21] to calculate the internal phase re-
sidual of each of the 17 possible layer group symmetries, and
the results for a typical image (¢lm no. 6295, in this case) are
listed in Table 1. The four layer groups with the internal
phase residual lower than 30‡ are p1, p2, p3, and p312. The
crystals clearly had a symmetry higher than p1. The phase
residual of the six images for p3 layer group ranged from
7.4^23.3‡, with the average being 16.4‡. The averaged phase
residuals for the p2 and p312 layer groups, on the other hand,
were 31.0 and 26.0‡, respectively. For the p6 layer group the
average was 49.8‡, even though the intensities of the calcu-
lated di¡raction pattern (Fig. 1b) showed hexagonal symme-
try. We therefore concluded that the 2D crystals of ArsA have
a p3 layer group symmetry. The ¢nal projection map with the
threefold symmetry imposed was calculated at a resolution of
2.4 nm, as shown in Fig. 1c.
In the projection map, we can see clearly one ring-like
structure per unit cell, with an outer diameter of about 8.5
nm and a central stain-excluding area of 1.5 nm across (Fig.
1c). The structure shows a hexagonal shape and has three high
electron density regions that are evenly distributed along the
ring. One structure interacts with its six neighboring rings via
the vertexes of the hexagon. The threefold symmetry of the
ArsA assembly, including the overall hexagonal shape and the
presence of three high-density regions, indicates that there
may be three monomers in the assembly on lipid layer. The
monomers are about 5U8 nm in projection as shown in Fig.
1c. The ring-like structures pack in the lattice in a relatively
dense way.
3.3. Trimeric structure of ArsA in solution observed by EM and
size-exclusion chromatography
The structure of ArsA ATPase in the solution containing
arsenite was examined by EM of negatively-stained protein
particles that was adsorbed onto the carbon ¢lm on EM grids.
Many ring-like particles with a diameter of 8^10 nm were
observed (Fig. 2). The ring-like structure are of the similar
size and shape as those observed in the projection map from
2D crystals (Fig. 1c). In fact, such dispersed ring-like struc-
tures sometimes were also observed on DMPS/DOPC mono-
layer under the same condition for 2D crystallization (data
not shown). This indicates that the ArsA protein in solution
and in 2D crystals adopt the same oligomeric state, most
likely a trimer.
To determine molecular weight and hence, the exact oligo-
meric state, of the ArsA protein in solution, size-exclusion
HPLC of puri¢ed ArsA protein was performed. In the pres-
ence of arsenite, the major peak of ArsA ATPase was found
to have a molecular weight of 180 ( þ 10) kDa (Fig. 3). The
majority of the ArsA protein in solution, therefore, is indeed
in a trimeric form, in agreement with the results from EM
(Figs. 1c and 2). The small shoulder eluted after the trimers
probably represents the monomeric ArsA protein of 63 kDa.
4. Discussion
4.1. Oligomeric state of ArsA
By 2D crystallization, EM and size-exclusion HPLC, we
have shown the ArsA protein, in the presence of arsenite,
adopts a trimeric form both in solution and on lipid layer.
The trimer has a ring-like structure, with a diameter of 8.5
nm. Each monomer has two symmetrical halves, most likely
representing the A1 and A2 sub-domains of the N- and C-
terminus of the polypeptide.
The cytosolic part of the Ars pump, ArsA ATPase is fairly
well characterized in the past decade on its biochemical prop-
erties in soluble form. However, up until now there are still no
evident data to give direct structural information of the pro-
tein. Some investigators have tried in to study the structure of
ArsA by indirect methods. The substrate-induced aggregation
of the protein was found a signi¢cant property of ArsA ATP-
ase. In 1991, Hsu et al. did systemic work on the protein’s
quaternary structure in solution [13]. By several types of tech-
niques, they concluded that ArsA ATPase forms a dimeric
structure in the presence of its allosteric substrate, arsenite
or antimonite, while in the absence of the substrates, the pro-
Fig. 2. Dispersion of ArsA ATPase particles in solution observed
under electron microscope after negative staining. Ring-like struc-
tures of 8^10 nm across, similar to those seen in projection map
from 2D crystals (Fig. 1c), are visible. The scale bar represents
10 nm.
Fig. 3. The elution curve of ArsA ATPase with arsenite bound.
Most of the protein is in a trimeric form, with a molecular weight
of 180 kDa. Indicated by arrows are the retention times of protein
standards: ovalbumin (43 kDa), albumin (67 kDa), alcohol dehy-
drogenase (150 kDa) and amylase (200 kDa). The void volume is at
12 min.
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tein exist in a monomeric form. Based on these results, models
on the ArsA ATPase’s conformation and structure changes
regulated by the allosteric ligands were built [7,11]. The struc-
ture of the Ars pump in the membrane was also predicted to
be a complex composed of homodimeric ArsA and ArsB sub-
units [15].
In our current work, however, we found that the ArsA
ATPase was a trimeric ring in its 2D crystals on negatively-
charged lipid monolayer in the presence of arsenite. The pro-
teins are adsorbed onto membranes by electrostatic force and
laterally form into 2D crystals by the interactions between the
molecules themselves. High ionic strength in the bu¡er inhib-
its the adsorption of proteins on the monolayer. This suggests
that there is no speci¢c interaction of ArsA proteins with
DMPS/DOPC monolayer. The observation of a large amount
of the same single rings on membrane and protein solution
supports this conclusion. This means that the ArsA ATPase in
solution is also in a trimeric aggregation state. This is further
supported by the measurement of ArsA ATPase’s molecular
weight by size-exclusion HPLC in solution. The apparent dis-
crepancies between Hsu’s work [13] and our results deserve
special attention.
In Hsu et al.’s work, they used enzyme inhibition kinetics,
chemical cross-linking, and light scattering technique to study
the oligomerization of ArsA ATPase in solution [13]. They
found that 5P-p-£uorosulfonylbenzoyladenosine (FSBA), the
adenine nucleotide analogue which can inhibit the ATP bind-
ing site on ATPases, inhibited its ATPase activity completely
in a inhibitor to protein molar ratio of 1.23:1 in the absence
of antimonite and 0.55:1 in the presence of antimonite. With
the assumption that with one ATP-binding site inhibited by
FSBA, the whole molecule loses its ATPase activity com-
pletely whether the molecule is a monomer or an oligomer,
they concluded that in the presence of antimonite the ArsA is
a homodimer. However, this assumption seemed to lack other
evidence, given the possible presence of non-speci¢c binding
of FSBA to the molecules mentioned by the authors. The zero
length chemical cross-linking that was used is very sensitive to
detect the presence of oligomers but less accurate to determine
the exact oligomeric state. In Hsu et al.’s work, they observed
the dimeric cross-linked species with the addition of antimon-
ite in the incubation bu¡er. This demonstrated the oligomeri-
zation in the presence of antimonite, but it may not be safe to
conclude that the protein was a dimer. Two adjacent mono-
mers in a trimer or tetramer may also be cross-linked. In fact,
they found the presence of a small amount of larger cross-
linked products. Similarly, light scattering is more reliable in
detecting oligomers than measuring their exact molecular
weights, particularly when the sample consists of a mixture
of di¡erent oligomers. Therefore, we believe that the trimeric
ArsA protein observed by EM and size-exclusion HPLC is a
more realistic oligomeric state of the protein when arsenite is
present.
The functional Ars pump in membranes needs the assembly
of ArsA and ArsB into a complex. What we reported here is
just the structure ArsA in solution but not the membrane
bound form. The exact quaternary structure of the complex,
especially the stoichiometry of ArsA and ArsB in the complex,
still needs further investigation.
4.2. The structure of ArsA monomer
The current projection map of ArsA trimer at 2.4 nm res-
olution (Fig. 1c) does not reveal much of the internal structure
of the ArsA monomer. However, The phase residual of the
images for the p312 layer group (Table 1), 26.0‡ in average for
the six images processed, is relatively low and much smaller
than the random value for this symmetry. This indicates that
the 2D crystals of ArsA possess a pseudo-twofold axis in the
crystal plane. This is consistent with the sequence homology
observed between the two halves of the polypeptide, A1 and
A2, and implies that the two halves of the monomer to have
similar structures. The recently reported three-dimensional
crystals belong to the I222 space group and also show pseu-
do-I4222 symmetry [14]. The authors also attribute the pseu-
do-fourfold axis to internal symmetry of the ArsA molecule.
4.3. Comparison with other ATPase pumps
As the core machinery of the arsenite resistance system in
bacteria, the arsenite pump is distinct with all the currently
well-characterized ATPase pumps [23]. Until today, three
families of ion-translocating ATPase pumps have been iden-
ti¢ed: the FoF1-ATPase in the bacterial, mitochondrial, and
chloroplast membrane; the vacuolar proton pumps found in
plant and fungal tonoplasts; the E1E2 cation-translocating
ATPase such as the sarcoplasmic reticulum Ca2-ATPase
and the plasma membrane Na/K-ATPase. Our projection
map is very di¡erent from any known structure of any of
these three ATPase protein families [24,25]. Since arsenite
and antimonite have distinct properties from hydrogen ions
and cations, the mechanism of their translocation through
membranes must be di¡erent from the other types of ion
pumps.
Comparison with the known structure of another ATP-
driven pump reveals interesting insights. The structure of
the ATP binding subunit HisP of the histidine transporter
from E. coli has been determined by X-ray crystallography
[26]. The protein is a member of the ATP binding cassette
(ABC) transporter family. HisP protein consists of a homo-
dimer of two 25 kDa polypeptides, each with one nucleotide
binding pocket. Inspections of the X-ray model of HisP pro-
tein and the projection map of ArsA (Fig. 1c) reveal interest-
ing similarities of the two proteins. In fact, both the shape and
dimensions are so similar, that three copies of the X-ray struc-
ture of HisP (¢gure 1a of [25]) can actually be ¢tted nicely
into the trimer in the projection map of ArsA (Fig. 1c). If we
assume the thickness of the ArsA protein is also 4.5 nm, just
like HisP, the ring-like structure in the ArsA projection map
would yield a molecular weight of 190 kDa, consistent with
the rest of our data and interpretations. Finally, we want to
point out that, even though no sequence homology has been
detected between the Ars protein and any ABC transporters,
it is still not unlikely that they have similar structures and
operate by similar mechanisms, at least in the ATP hydrolysis
domains.
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